AEHR - Aehr Test Systems Stock Price, Fair Value and News

11.74USD-0.24 (-2.00%)Market Closed

Market Summary

USD11.74-0.24

Market Closed

-2.00%

AEHR Alerts

Big fall in Revenue (Y/Y)

Big fall in earnings (Y/Y)
Losses in recent quarter

AEHR Stock Price

View Fullscreen

AEHR RSI Chart

AEHR Valuation

Market Cap

339.5M

Price/Earnings (Trailing)

22.04

Price/Sales (Trailing)

4.72

EV/EBITDA

15.92

Price/Free Cashflow

75.22

AEHR Price/Sales (Trailing)

AEHR Profitability

Operating Margin

49.49%

EBT Margin

21.50%

Return on Equity

17.81%

Return on Assets

15.16%

Free Cashflow Yield

1.33%

AEHR Fundamentals

AEHR Revenue

Revenue (TTM)

71.9M

Rev. Growth (Yr)

-56.04%

Rev. Growth (Qtr)

-64.71%

AEHR Earnings

Earnings (TTM)

15.4M

Earnings Growth (Yr)

-135.6%

Earnings Growth (Qtr)

-124.16%

Breaking Down AEHR Revenue

Last 7 days

13.5%

Last 30 days

-3.4%

Last 90 days

-19.3%

Trailing 12 Months

-53.8%

How does AEHR drawdown profile look like?

AEHR Financial Health

Current Ratio

10.06

AEHR Investor Care

Shares Dilution (1Y)

2.03%

Diluted EPS (TTM)

0.52

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	71.9M	0	0	0
2023	63.0M	65.0M	74.9M	81.5M
2022	38.2M	50.8M	55.9M	61.1M
2021	12.7M	16.6M	20.2M	28.2M
2020	25.8M	22.3M	18.8M	13.6M
2019	21.1M	21.1M	21.8M	22.8M
2018	29.0M	29.6M	27.3M	25.3M
2017	13.8M	18.9M	20.6M	24.3M
2016	14.7M	14.5M	13.2M	12.8M
2015	13.6M	10.0M	13.1M	15.1M
2014	17.6M	19.7M	19.5M	17.2M
2013	17.9M	16.5M	15.4M	15.3M
2012	14.6M	15.5M	16.2M	17.4M
2011	13.2M	13.7M	15.7M	16.0M
2010	0	11.7M	12.2M	12.7M

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Aehr Test Systems

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Apr 29, 2024	sporck alistair n	sold (taxes)	-1,827	12.1	-151	vp contactor business unit
Apr 29, 2024	erickson gayn	sold (taxes)	-6,606	12.1	-546	president and ceo
Apr 29, 2024	ray-chaudhuri avijit k.	sold (taxes)	-1,210	12.1	-100	executive vp of r&d
Apr 29, 2024	richmond donald p. ii	sold (taxes)	-1,161	12.1	-96.00	cto
Apr 29, 2024	rogers vernon	sold (taxes)	-1,621	12.1	-134	exec vp of sales & mktg.
Apr 29, 2024	engineer adil	sold (taxes)	-1,960	12.1	-162	chief operating officer
Apr 18, 2024	sporck alistair n	sold (taxes)	-4,144	10.82	-383	vp contactor business unit
Apr 14, 2024	rogers vernon	sold (taxes)	-9,540	11.55	-826	exec vp of sales & mktg.
Apr 14, 2024	richmond donald p. ii	sold (taxes)	-7,172	11.55	-621	cto
Apr 14, 2024	erickson gayn	sold (taxes)	-39,997	11.55	-3,463	president and ceo

Which funds bought or sold AEHR recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 30, 2024	TFC Financial Management, Inc.	unchanged	-	-2,275	1,997	-%
Apr 30, 2024	Avior Wealth Management, LLC	new	-	359	359	-%
Apr 29, 2024	COMMONWEALTH EQUITY SERVICES, LLC	sold off	-100	-534,000	-	-%
Apr 29, 2024	HERITAGE INVESTORS MANAGEMENT CORP	unchanged	-	-684,000	600,000	0.02%
Apr 25, 2024	Bank of New York Mellon Corp	reduced	-51.76	-4,048,750	1,178,760	-%
Apr 25, 2024	Zurcher Kantonalbank (Zurich Cantonalbank)	unchanged	-	-67,146	58,925	-%
Apr 25, 2024	SIMPLEX TRADING, LLC	added	4.49	-513,000	488,000	-%
Apr 24, 2024	DekaBank Deutsche Girozentrale	unchanged	-	-41,000	32,000	-%
Apr 23, 2024	RICE HALL JAMES & ASSOCIATES, LLC	new	-	958,359	958,359	0.06%
Apr 23, 2024	ARCADIA INVESTMENT MANAGEMENT CORP/MI	unchanged	-	-5,377	4,705	-%

Are Funds Buying or Selling AEHR?

Are funds buying AEHR calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own AEHR

No. of Funds

Unveiling Aehr Test Systems's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	vanguard group inc	5.24%	1,508,759	SC 13G
Feb 06, 2024	goldman sachs group inc	0.6%	187,005	SC 13G/A
Jan 26, 2024	blackrock inc.	7.2%	2,077,807	SC 13G
Apr 11, 2023	awm investment company, inc.	4.8%	1,328,713	SC 13G/A
Feb 14, 2023	collaborative holdings management lp	0%	0	SC 13G/A
Feb 14, 2023	awm investment company, inc.	5.9%	1,648,319	SC 13G
Feb 09, 2023	fmr llc	-	0	SC 13G/A
Feb 07, 2023	goldman sachs group inc	5.2%	1,446,690	SC 13G
Feb 14, 2022	collaborative holdings management lp	5.7%	1,533,440	SC 13G/A
Feb 09, 2022	fmr llc	-	0	SC 13G

Recent SEC filings of Aehr Test Systems

View All Filings

Date Filed	Form Type	Document
Apr 30, 2024	4	Insider Trading
Apr 30, 2024	4	Insider Trading
Apr 30, 2024	4	Insider Trading
Apr 30, 2024	4	Insider Trading
Apr 30, 2024	4	Insider Trading
Apr 30, 2024	4	Insider Trading
Apr 18, 2024	4	Insider Trading
Apr 15, 2024	4	Insider Trading
Apr 15, 2024	4	Insider Trading
Apr 15, 2024	4	Insider Trading

Peers (Alternatives to Aehr Test Systems)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
NVDA	2.1T	60.9B	-4.38%	198.87%	69.81	34.1	125.85%	581.31%
AMD	233.2B	22.8B	-12.25%	76.59%	208.99	10.23	-3.90%	-35.30%
AMAT	161.3B	26.5B	-3.68%	75.87%	22.53	6.09	0.88%	10.98%
INTC	129.2B	55.2B	-31.02%	0.97%	31.79	2.34	-2.09%	242.32%
ADI	96.2B	11.6B	1.43%	9.90%	34.16	8.32	-8.03%	-17.90%
MID-CAP
AMKR	7.5B	6.5B	0.34%	44.61%	20.72	1.15	-8.30%	-53.02%
CRUS	4.5B	1.8B	-4.31%	4.14%	25.72	2.53	-11.16%	-46.12%
ACLS	3.3B	1.1B	-7.17%	-15.90%	13.49	2.94	22.89%	34.51%
DIOD	3.3B	1.7B	3.56%	-11.38%	14.37	1.96	-16.94%	-31.42%
AMBA	1.9B	226.5M	-9.45%	-27.07%	-11.02	8.25	-32.92%	-159.10%
SMALL-CAP
ACMR	1.5B	557.7M	-12.42%	173.23%	19.37	2.69	43.44%	97.00%
AOSL	595.3M	640.0M	-0.77%	-10.44%	-34.71	0.93	-19.44%	-128.49%
AEHR	339.5M	71.9M	-3.39%	-53.83%	22.04	4.72	14.14%	8.17%
ATOM	117.8M	550.0K	-24.68%	-43.00%	-6.01	214.12	43.98%	-6.63%
ASYS	69.3M	116.7M	-10.91%	-44.53%	-3.61	0.59	15.07%	-240.88%

Aehr Test Systems News

Latest updates

Aehr Test Systems Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	-64.7%	7,563	21,431	20,624	22,269	17,206	14,815	10,671	20,289	15,283	9,611	5,646	7,638	5,267	1,683	2,012	3,773	6,111	6,874	5,533	7,242	3,163
Cost Of Revenue	-57.9%	4,407	10,473	10,643	10,790	8,331	6,904	6,190	9,821	8,886	5,092	3,365	4,104	3,373	1,306	1,785	3,866	3,120	3,672	3,262	3,863	2,891
Gross Profit	-71.2%	3,156	10,958	9,981	11,479	8,875	7,911	4,481	10,468	6,397	4,519	2,281	3,534	1,894	377	227	-93.00	2,991	3,202	2,271	3,379	272
Operating Expenses	-5.2%	5,202	5,490	5,866	5,840	5,082	4,426	4,023	4,648	4,141	3,802	3,274	2,933	2,546	2,321	2,414	2,748	2,736	2,952	2,700	3,256	3,388
S&GA Expenses	-12.9%	3,063	3,518	3,409	3,587	3,250	2,875	2,525	2,993	2,612	2,489	1,953	1,904	1,643	1,501	1,514	1,674	1,891	2,157	1,808	2,018	1,850
R&D Expenses	8.5%	2,139	1,972	2,457	2,253	1,832	1,551	1,498	1,655	1,529	1,313	1,321	1,029	903	820	900	854	845	795	892	1,120	931
EBITDA Margin	-12.1%	0.25*	0.29*	0.28*	0.25*	0.25*	0.22*	0.18*	0.19*	0.12*	0.06*	-0.05*	-0.11*	-0.42*	-	-	-	-	-	-	-	-
Interest Expenses	-7.4%	584	631	581	487	374	263	121	22.00	1.00	-1.00	-9.00	-36.00	-10.00	12.00	13.00	-17.00	13.00	2.00	12.00	-176	-76.00
Income Taxes	-65.0%	7.00	20.00	16.00	11.00	17.00	18.00	14.00	10.00	24.00	34.00	23.00	-215	34.00	4.00	215	-62.00	14.00	6.00	6.00	6.00	-2.00
Earnings Before Taxes	-124.0%	-1,464	6,109	4,690	6,122	4,149	3,743	603	5,804	2,267	751	719	567	-701	-1,962	-108	-2,875	259	257	-407	116	-3,203
EBT Margin	-16.8%	0.22*	0.26*	0.25*	0.23*	0.23*	0.20*	0.17*	0.19*	0.11*	0.05*	-0.07*	-0.13*	-0.44*	-	-	-	-	-	-	-	-
Net Income	-124.2%	-1,471	6,089	4,674	6,111	4,132	3,725	589	5,794	2,243	717	696	567	-735	-1,966	107	-2,885	245	251	-413	110	-3,201
Net Income Margin	-16.8%	0.21*	0.26*	0.25*	0.22*	0.23*	0.20*	0.17*	0.19*	0.11*	0.04*	-0.07*	-0.12*	-0.43*	-	-	-	-	-	-	-	-
Free Cashflow	-340.4%	-3,087	-701	3,617	4,684	-1,202	-210	5,377	-965	-3,022	3,264	1,815	-212	-267	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	0.4%	102	101	105	98.00	84.00	68.00	62.00	62.00	57.00	58.00	24.00	22.00	19.00	17.00	19.00	21.00	22.00	24.00	22.00	21.00	25.00
Current Assets	0.6%	92.00	92.00	96.00	89.00	77.00	66.00	59.00	60.00	55.00	56.00	22.00	19.00	16.00	14.00	16.00	18.00	18.00	21.00	18.00	20.00	24.00
Cash Equivalents	-5.5%	48.00	51.00	51.00	30.00	17.00	19.00	36.00	32.00	32.00	35.00	7.00	5.00	5.00	4.00	6.00	6.00	5.00	5.00	5.00	6.00	12.00
Inventory	12.6%	38.00	34.00	32.00	24.00	22.00	18.00	17.00	15.00	14.00	13.00	10.00	9.00	8.00	9.00	8.00	8.00	9.00	10.00	9.00	9.00	9.00
Net PPE	-1.1%	3.00	3.00	3.00	3.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00
Liabilities	7.7%	15.00	14.00	25.00	23.00	16.00	11.00	10.00	11.00	13.00	17.00	10.00	10.00	8.00	6.00	6.00	7.00	5.00	8.00	7.00	6.00	10.00
Current Liabilities	15.3%	9.00	8.00	19.00	16.00	9.00	11.00	10.00	11.00	13.00	17.00	9.00	9.00	7.00	4.00	4.00	4.00	3.00	6.00	5.00	6.00	10.00
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	0.00	0.00	1.00	1.00	-	-	-	-	-
LT Debt, Current	-	-	-	-	-	-	-	-	-	-	-	-	2.00	1.00	1.00	1.00	1.00	-	-	-	-	6.00
LT Debt, Non Current	-	-	-	-	-	-	-	-	-	-	-	-	-	0.00	0.00	1.00	1.00	-	-	-	-	-
Shareholder's Equity	-0.8%	86.00	87.00	80.00	76.00	69.00	57.00	52.00	51.00	44.00	41.00	14.00	11.00	10.00	11.00	12.00	14.00	17.00	16.00	15.00	15.00	15.00
Retained Earnings	-3.5%	-43.01	-41.54	-47.63	-52.31	-58.42	-62.55	-66.27	-66.86	-72.66	-74.90	-75.62	-76.31	-76.88	-76.17	-74.20	-74.29	-71.40	-71.65	-71.90	-71.48	-71.59
Additional Paid-In Capital	0.6%	129	129	128	128	127	119	118	118	117	116	90.00	88.00	87.00	87.00	86.00	86.00	86.00	85.00	85.00	84.00	84.00
Shares Outstanding	-	29.00	-	29.00	29.00	28.00	28.00	27.00	27.00	27.00	27.00	24.00	23.00	24.00	-	-	-	-	-	-	-	-
Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.02	-0.02	-0.02	-0.02	-0.02	-0.02
Float	-	-	-	-	-	-	-	-	-	-	1*	-	-	-	34.00	-	-	-	38.00	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	-418.2%	-2,824	-545	3,901	5,868	-1,123	-195	5,461	-767	-2,936	3,337	1,874	-190	-256	-2,898	643	-1,384	-364	-86.00	-190	-844	-1,836
Share Based Compensation	-8.5%	584	638	522	653	592	793	710	820	880	718	588	303	271	257	270	299	207	205	199	200	225
Cashflow From Investing	-68.6%	-263	-156	17,716	6,816	-7,721	-17,667	-84.00	-198	-86.00	-73.00	-59.00	-22.00	-11.00	-147	-47.00	-14.00	-26.00	-73.00	-50.00	-49.00	-21.00
Cashflow From Financing	-37.8%	158	254	-694	184	7,242	620	-724	361	26.00	25,239	135	77.00	1,518	175	190	1,749	130	231	62.00	-5,986	123

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

AEHR Income Statement

2024-02-29

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Feb. 29, 2024	Feb. 28, 2023	Feb. 29, 2024	Feb. 28, 2023
Revenues
Total Revenue	$ 7,563	$ 17,206	$ 49,618	$ 42,692
Cost of revenue:
Total cost of revenue	4,407	8,331	25,523	21,425
Gross profit	3,156	8,875	24,095	21,267
Operating expenses:
Research and development	2,139	1,832	6,568	4,881
Selling, general and administrative	3,063	3,250	9,990	8,650
Total operating expenses	5,202	5,082	16,558	13,531
Income (loss) from operations	(2,046)	3,793	7,537	7,736
Interest income, net	584	374	1,796	758
Other income (expense), net	(2)	(18)	2	1
Income (loss) before provision for income taxes	(1,464)	4,149	9,335	8,495
Provision for income taxes	7	17	43	49
Net income (loss)	$ (1,471)	$ 4,132	$ 9,292	$ 8,446
Net income (loss) per share:
Basic	$ (0.05)	$ 0.15	$ 0.32	$ 0.31
Diluted	$ (0.05)	$ 0.14	$ 0.31	$ 0.29
Shares used in per share calculations:
Basic	28,866	27,893	28,773	27,571
Diluted	28,866	29,373	29,670	29,080
Product [Member]
Revenues
Total Revenue	$ 6,730	$ 16,120	$ 45,924	$ 39,715
Cost of revenue:
Total cost of revenue	3,948	7,728	23,574	19,739
Services [Member]
Revenues
Total Revenue	833	1,086	3,694	2,977
Cost of revenue:
Total cost of revenue	$ 459	$ 603	$ 1,949	$ 1,686

AEHR Balance Sheet

2024-02-29

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Feb. 29, 2024	May 31, 2023
Current assets:
Cash and cash equivalents	$ 47,581	$ 30,054
Short-term investments	0	17,853
Accounts receivable, net	5,468	16,594
Inventories	38,085	23,908
Prepaid expenses and other current assets	1,215	621
Total current assets	92,349	89,030
Property and equipment, net	3,150	2,759
Operating lease right-of-use assets, net	5,863	6,123
Other non-current assets	234	231
Total assets	101,596	98,143
Current liabilities:
Accounts payable	4,979	9,206
Accrued expenses	3,287	4,143
Operating lease liabilities, short-term	428	137
Deferred revenue, short-term	486	2,822
Total current liabilities	9,180	16,308
Operating lease liabilities, long-term	5,878	6,163
Deferred revenue, long-term	0	31
Other long-term liabilities	41	41
Total liabilities	15,099	22,543
Shareholders' equity:
Preferred stock, $0.01 par value: Authorized: 10,000 shares; Issued and outstanding: none	0	0
Common stock, $0.01 par value: Authorized: 75,000 shares; Issued and outstanding: 28,906 shares and 28,539 shares at February 29, 2024 and May 31, 2023, respectively	289	285
Additional paid-in-capital	129,366	127,776
Accumulated other comprehensive loss	(144)	(155)
Accumulated deficit	(43,014)	(52,306)
Total shareholders' equity	86,497	75,600
Total liabilities and shareholders' equity	$ 101,596	$ 98,143

About Aehr Test Systems

Aehr Test Systems provides test solutions for testing, burning-in, and semiconductor devices in wafer level, singulated die, and package part form, and installed systems worldwide. Its product portfolio includes FOX-XP and FOX-NP systems that are full wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize range of devices, including silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices. The company also offers FOX-CP system, a low-cost single-wafer compact test solution for logic, memory, and photonic devices; FOX WaferPak Contactor, a full wafer contactor capable of testing wafers up to 300mm that enables integrated circuit manufacturers to perform test, burn-in, and stabilization of full wafers on the FOX-P systems. In addition, it provides FOX DiePak Carrier, a reusable temporary package that enables IC manufacturers to perform final test and burn-in of bare die and modules; and FOX DiePak Loader. The company was incorporated in 1977 and is headquartered in Fremont, California.

CEO	Mr. Gayn Erickson
WEBSITE	aehr.com
INDUSTRY	Semiconductors
EMPLOYEES	104

Aehr Test Systems Frequently Asked Questions

What is the ticker symbol for Aehr Test Systems? What does AEHR stand for in stocks?

AEHR is the stock ticker symbol of Aehr Test Systems. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Aehr Test Systems (AEHR)?

As of Tue Apr 30 2024, market cap of Aehr Test Systems is 346.4 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of AEHR stock?

You can check AEHR's fair value in chart for subscribers.

What is the fair value of AEHR stock?

You can check AEHR's fair value in chart for subscribers. The fair value of Aehr Test Systems is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Aehr Test Systems is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for AEHR so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Aehr Test Systems a good stock to buy?

The fair value guage provides a quick view whether AEHR is over valued or under valued. Whether Aehr Test Systems is cheap or expensive depends on the assumptions which impact Aehr Test Systems's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for AEHR.

What is Aehr Test Systems's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Apr 30 2024, AEHR's PE ratio (Price to Earnings) is 22.49 and Price to Sales (PS) ratio is 4.82. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. AEHR PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Aehr Test Systems's stock?

In the past 10 years, Aehr Test Systems has provided 0.166 (multiply by 100 for percentage) rate of return.